Newamsterdam Pharma Company Nv (NAMS)

May 25, 2026

Technical Reactions to NAMS Trends in Macro Strategies - Stock Traders Daily

May 25, 2026

May 22, 2026

NewAmsterdam Pharma Co NV (HAM:KH6) Cyclically Adjusted Pri - GuruFocus

May 22, 2026

May 18, 2026

NewAmsterdam Pharma Insiders Who Sold Avert US$477m Market Cap Dip - Moomoo

May 18, 2026

May 14, 2026

Bain Life Sciences trims NewAmsterdam (NAMS) holding to about 3.3% - Stock Titan

May 14, 2026

May 14, 2026

Trading the Move, Not the Narrative: (NAMS) Edition - Stock Traders Daily

May 14, 2026

May 14, 2026

NewAmsterdam Pharma Company N.V.Ordinary Shares (NQ: NAMS - FinancialContent

May 14, 2026

May 14, 2026

Industry Analysts Just Made A Substantial Upgrade To Their NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Revenue Forecasts - Sahm

May 14, 2026

May 13, 2026

NewAmsterdam Pharma Company N.V. (NAMS) Eps Diluted (TTM) - Zacks Investment Research

May 13, 2026

May 12, 2026

NAMS: Interim PREVAIL results expected Q1 next year, with strong efficacy and broad market potential - TradingView

May 12, 2026

May 12, 2026

Piper Sandler reiterates NewAmsterdam Pharma stock rating at overweight By Investing.com - Investing.com Nigeria

May 12, 2026

May 12, 2026

Piper Sandler reiterates NewAmsterdam Pharma stock rating at overweight - Investing.com

May 12, 2026

May 12, 2026

HC Wainwright Has Negative Forecast for NAMS Q2 Earnings - MarketBeat

May 12, 2026

May 12, 2026

NewAmsterdam Pharma stock hits all-time high at 42.02 USD By Investing.com - Investing.com India

May 12, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 11, 2026

NAMS SEC FilingsNewAmsterdam Pharma Company N.V 10-K, 10-Q, 8-K Forms - Stock Titan

May 11, 2026

May 11, 2026

NewAmsterdam Pharma Company N.V. (NAMS) Discusses Clinical Development Update and Interim Analysis Plans for PREVAIL TrialSlideshow (NASDAQ:NAMS) 2026-05-11 - Seeking Alpha

May 11, 2026

May 11, 2026

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance

May 11, 2026

May 11, 2026

Why NewAmsterdam Pharma (NAMS) Is Up 29.7% After Detailing Obicetrapib Phase 3 And Launch Milestones - simplywall.st

May 11, 2026

May 11, 2026

NewAmsterdam Pharma stock hits all-time high at 42.02 USD - Investing.com

May 11, 2026

May 11, 2026

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May - GlobeNewswire

May 11, 2026

May 10, 2026

Number of shareholders of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView

May 10, 2026

May 10, 2026

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

May 10, 2026

May 09, 2026

NewAmsterdam Pharma Company NV (NAMS) reports Q1 loss, tops revenue estimates - MSN

May 09, 2026

May 09, 2026

NewAmsterdam Pharma Hits Day High with 12.46% Surge in Stock Price - Markets Mojo

May 09, 2026

May 09, 2026

NewAmsterdam Pharma (NAMS) Deep Quarterly Loss Tests Bullish Growth And Valuation Narratives - Sahm

May 09, 2026

May 08, 2026

Why (NAMSW) Price Action Is Critical for Tactical Trading - Stock Traders Daily

May 08, 2026

May 08, 2026

NewAmsterdam says its 9,500-patient heart trial gets an interim look in 4Q26 - Stock Titan

May 08, 2026

May 08, 2026

Do NewAmsterdam Pharma’s (NAMS) Dilution Plans Reframe Its Path to Funding Ongoing Losses? - Yahoo Finance

May 08, 2026

May 08, 2026

NewAmsterdam Pharma Sets PREVAIL Interim Analysis for Q4 2026 on Encouraging Blinded Trends - Yahoo Finance

May 08, 2026

May 07, 2026

NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 07, 2026

May 07, 2026

NewAmsterdam Pharma (NASDAQ:NAMS) Beats Q1 Revenue and EPS Estimates as Key Trial Catalysts Loom - ChartMill

May 07, 2026

May 07, 2026

Earnings Flash (NAMS) NewAmsterdam Pharma Company N.V. Reports Q1 Revenue $3.0M, vs. FactSet Est of $1.1M - marketscreener.com

May 07, 2026

May 07, 2026

Earnings Flash (NAMS) NewAmsterdam Pharma Company N.V. Reports Q1 Revenue $3.0M, Vs. FactSet Est of $1.1M - Moomoo

May 07, 2026

May 07, 2026

NewAmsterdam Pharma (NAMS) posts Q1 2026 loss with $707M cash and key trial milestones - Stock Titan

May 07, 2026

May 07, 2026

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results - marketscreener.com

May 07, 2026

May 07, 2026

NewAmsterdam Pharma (NASDAQ: NAMS) reports $48M Q1 2026 loss - Stock Titan

May 07, 2026

May 07, 2026

Number of shareholders of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

May 07, 2026

May 06, 2026

All eyes on NewAmsterdam Pharma earnings as pipeline advances By Investing.com - Investing.com Nigeria

May 06, 2026

May 06, 2026

All eyes on NewAmsterdam Pharma earnings as pipeline advances - Investing.com

May 06, 2026

May 06, 2026

FMR LLC boosts disclosure: PHARMA COMPANY NV (NAMS) 8.77M shares reported - Stock Titan

May 06, 2026

May 06, 2026

[ARS] NewAmsterdam Pharma Co N.V. SEC Filing - Stock Titan

May 06, 2026

May 06, 2026

NewAmsterdam Pharma (NAMS) outlines 2026 AGM votes, ESPP and share issuance powers - Stock Titan

May 06, 2026

May 03, 2026

(NAMS) Volatility Zones as Tactical Triggers - Stock Traders Daily

May 03, 2026

May 01, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2026

May 01, 2026

Five new hires at NewAmsterdam get stock awards covering 65,800 shares - Stock Titan

May 01, 2026

May 01, 2026

Pictet Asset Management Holding SA Lowers Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

May 01, 2026

Apr 30, 2026

Jennison Associates LLC Trims Stock Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

Apr 30, 2026

Apr 29, 2026

What sustainable investing NewAmsterdam (NAMSW)? (+5.61%) 2026-04-29Community Watchlist - Newser

Apr 29, 2026

Apr 29, 2026

143,549 Shares in NewAmsterdam Pharma Company N.V. $NAMS Bought by Moody Aldrich Partners LLC - MarketBeat

Apr 29, 2026